Abstract

The cofactor tetrahydrobiopterin plays critical roles in the modulation of the signaling molecules dopamine, serotonin, and nitric oxide. Deficits in cofactor synthesis have been associated with several human hereditary diseases. Responsibility for the regulation of cofactor pools resides with the first enzyme in its biosynthetic pathway, GTP cyclohydrolase I. Because organisms must be able to rapidly respond to environmental and developmental cues to adjust output of these signaling molecules, complex regulatory mechanisms are vital for signal modulation. Mammalian GTP cyclohydrolase is subject to end-product inhibition via an associated regulatory protein and to positive regulation via phosphorylation, although target residues are unknown. GTP cyclohydrolase is composed of a highly conserved homodecameric catalytic core and non-conserved N-terminal domains proposed to be regulatory sites. We demonstrate for the first time in any organism that the N-terminal arms of the protein serve regulatory functions. We identify two different modes of regulation of the enzyme mediated through the N-terminal domains. The first is end-product feedback inhibition, catalytically similar to that of the mammalian enzyme, except that feedback inhibition by the cofactor requires sequences in the N-terminal arms rather than a separate regulatory protein. The second is a novel inhibitory interaction between the N-terminal arms and the active sites, which can be alleviated through the phosphorylation of serine residues within the N termini. Both mechanisms allow for acute and highly responsive regulation of cofactor production as required by downstream signaling pathways.

Highlights

  • Mammalian GTPCH is regulated by a variety of mechanisms, the best characterized of which is end-product feedback inhibition by BH4 [19]

  • We show that the N-terminal domains of these two isoforms serve as substrates for protein kinase A (PKA) and protein kinase C (PKC)

  • It has been hypothesized that the N-terminal domain of GTPCH plays regulatory roles, we present here the first direct evidence of this phenomenon

Read more

Summary

Drosophila GTP Cyclohydrolase Isoform Regulation

Iological conditions and disease states [24, 25]. The mechanism by which DAHP is able to inhibit GTPCH is similar to that of BH4 in that GFRP is required for the inhibition and the inhibition is non-competitive [26, 27]. Co-expression of GTPCH type I and GTPCH type II, a truncated and non-functional GTPCH protein, in human blood cells depresses the level of GTPCH type I protein [31] It remains unclear whether this mechanism is employed more universally for negative regulation of GTPCH in mammalian cells. The GTPCH polypeptides from all species analyzed to date have a non-conserved N-terminal domain that extends as an “arm” from the catalytic core. These arms have been variously proposed to be regulatory domains or docking sites for interacting proteins, evidence is lacking to confirm these hypotheses. The N-terminal extensions serve as functional homologs of the mammalian GFRP despite the non-alignment of sequence, in that they are capable of directing non-competitive inhibition by BH4 and DAHP in the absence of GFRP

EXPERIMENTAL PROCEDURES
Phosphate Vmax
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call